Radioactive Iodine Shows Limited Benefit in Tall Cell Cancer
Summary
No remissions or partial responses are observed over 4 years among patients with high-risk tall cell variant papillary thyroid cancer treated with radioactive iodine.
Description from Medscape.
Who is covering this
-
Radioactive Iodine Shows Limited Benefit in Tall Cell Cancer
No remissions or partial responses are observed over 4 years among patients with high-risk tall cell variant papillary thyroid cancer treated with radioactive iodine.
Comments
Comments need JavaScript.